Attached files
| file | filename |
|---|---|
| EX-4.1 - EXHIBIT 4.1 - Cyclerion Therapeutics, Inc. | tm206168d1_ex4-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Cyclerion Therapeutics, Inc. | tm206168d1_ex21-1.htm |
| EX-23.1 - EXHIBIT 23.1 - Cyclerion Therapeutics, Inc. | tm206168d1_ex23-1.htm |
| EX-31.1 - EXHIBIT 31.1 - Cyclerion Therapeutics, Inc. | tm206168d1_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Cyclerion Therapeutics, Inc. | tm206168d1_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - Cyclerion Therapeutics, Inc. | tm206168d1_ex32-2.htm |
| 10-K - FORM 10-K - Cyclerion Therapeutics, Inc. | tm206168d1_10k.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Peter M. Hecht, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Annual Report on Form 10-K of Cyclerion Therapeutics, Inc. for the period ended December 31, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in such Form 10-K fairly presents, in all material respects, the financial condition and results of operations of Cyclerion Therapeutics, Inc.
| Date: March 12, 2020 | By: | /s/ Peter M. Hecht | |
| Name: | Peter M. Hecht | ||
| Title: | Chief Executive Officer (Principal Executive Officer) | ||